Mykhaloiko I, Yatsyshyn R. Apixaban versus warfarin in nephrotic syndrome: thromboembolic events, bleeding risk and changes in profibrotic and inflammatory cytokines. Ukr. J. Nephrol. Dial. [Internet]. 2026Jun.11 [cited 2026Jun.26];0(2(90):20-1. Available from: https://ukrjnd.com.ua/index.php/journal/article/view/1038